Claro Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
14,957
+1,840
+14% +$138K 0.13% 141
2025
Q4
$1.04M Buy
13,117
+385
+3% +$30.5K 0.14% 130
2025
Q3
$1.05M Sell
12,732
-155
-1% -$12.2K 0.15% 119
2025
Q2
$1.04M Sell
12,887
-686
-5% -$52.9K 0.17% 114
2025
Q1
$1.09M Buy
13,573
+62
+0.5% +$5.16K 0.15% 132
2024
Q4
$1.11M Buy
13,511
+28
+0.2% +$2.33K 0.15% 126
2024
Q3
$1.11M Buy
13,483
+308
+2% +$23K 0.14% 136
2024
Q2
$925K Sell
13,175
-104
-0.8% -$7.42K 0.14% 141
2024
Q1
$984K Buy
+13,279
New +$926K 0.17% 132
2019
Q1
Sell
-196
Closed -$9K 639
2018
Q4
$9K Buy
+196
New +$8.41K 0.01% 702

Other funds holding MET

Claro Advisors's MET Position: Q1 2026 in Review

Claro Advisors increased its MetLife (MET) stake by 14% in Q1 2026, buying an estimated $138K and bringing the position to 14,957 shares worth $1.06M. The position accounts for 0.13% of the portfolio, ranked #141.

Claro Advisors first reported a position in MET in Q4 2018 and has held it in 10 quarters since. The position peaked at $1.11M in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Claro Advisors held 14,957 shares of MetLife worth $1.06M as of Q1 2026.
  • Claro Advisors bought 1,840 MetLife shares in Q1 2026, an estimated $138K.
  • MetLife made up 0.13% of Claro Advisors's portfolio in Q1 2026, its #141 holding.
  • Claro Advisors first reported a position in MetLife in Q4 2018 and has held it in 10 quarters since.
  • Claro Advisors's MetLife position peaked at $1.11M in Q3 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.